Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Presage Biosciences
MedTech
Takeda, Presage microdose cancers to see how immune cells fight
Takeda is examining two therapies that could help break down the barriers protecting solid tumors from the body's immune system.
Conor Hale
Apr 13, 2022 4:34pm
Merck taps tumor-microdosing Presage for phase 0 trials
Mar 2, 2021 9:50am
Presage inks 3rd deal around phase 0 studies—with more to come
Aug 27, 2019 8:00am
Celgene taps Presage's microdosing tech for phase 0 cancer studies
May 2, 2019 8:00am
Celgene, Takeda invest in intratumoral microdosing firm Presage
Jul 17, 2018 8:00am
